MYRIAD GENETICS INC — Form 10-Q

Myriad adopted a revised Non-Employee Director Compensation Policy effective June 2026. Annual base retainer is $60,000 for all directors; Board Chair receives additional $120,000; committee chairs receive $20,000–$28,000 additional retainer depending on committee; committee members receive $10,000–$13,500 additional retainer. Equity awards valued at $350,000 are granted annually (capped at $500,000/calendar year), divided by stock price on grant date, with one-year vesting or next annual meeting, whichever is earlier. The policy includes standard Sarbanes-Oxley certifications from CEO Samraat S. Raha and CFO Benjamin R. Wheeler dated July 31, 2026, confirming the 10-Q fairly presents financial condition and internal controls are effective.